全文获取类型
收费全文 | 39698篇 |
免费 | 136篇 |
国内免费 | 174篇 |
专业分类
系统科学 | 187篇 |
丛书文集 | 547篇 |
教育与普及 | 76篇 |
理论与方法论 | 126篇 |
现状及发展 | 17650篇 |
研究方法 | 1632篇 |
综合类 | 19165篇 |
自然研究 | 625篇 |
出版年
2013年 | 319篇 |
2012年 | 569篇 |
2011年 | 1173篇 |
2010年 | 255篇 |
2008年 | 698篇 |
2007年 | 827篇 |
2006年 | 768篇 |
2005年 | 817篇 |
2004年 | 823篇 |
2003年 | 723篇 |
2002年 | 738篇 |
2001年 | 1244篇 |
2000年 | 1188篇 |
1999年 | 805篇 |
1994年 | 389篇 |
1992年 | 773篇 |
1991年 | 551篇 |
1990年 | 618篇 |
1989年 | 601篇 |
1988年 | 566篇 |
1987年 | 613篇 |
1986年 | 655篇 |
1985年 | 818篇 |
1984年 | 596篇 |
1983年 | 521篇 |
1982年 | 479篇 |
1981年 | 489篇 |
1980年 | 517篇 |
1979年 | 1303篇 |
1978年 | 1008篇 |
1977年 | 933篇 |
1976年 | 756篇 |
1975年 | 782篇 |
1974年 | 1090篇 |
1973年 | 943篇 |
1972年 | 953篇 |
1971年 | 1072篇 |
1970年 | 1476篇 |
1969年 | 1150篇 |
1968年 | 1067篇 |
1967年 | 1066篇 |
1966年 | 1000篇 |
1965年 | 747篇 |
1959年 | 376篇 |
1958年 | 720篇 |
1957年 | 477篇 |
1956年 | 407篇 |
1955年 | 365篇 |
1954年 | 414篇 |
1948年 | 285篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
971.
Phytanic acid is a branched-chain fatty acid that accumulates in a variety of metabolic disorders. High levels of phytanic
acid found in patients can exceed the millimolar range and lead to severe symptoms. Degradation of phytanic acid takes place
by α-oxidation inside the peroxisome. A deficiency of its breakdown, leading to elevated levels, can result from either a
general peroxisomal dysfunction or from a defect in one of the enzymes involved in α-oxidation. Research on Refsum disease,
belonging to the latter group of disorders and characterized by a deficiency of the first enzyme of α-oxidation, has extended
our knowledge of phytanic acid metabolism and pathology of the disease greatly over the past few decades. This review will
centre on this research on phytanic acid: its origin, the mechanism by which its α-oxidation takes place, its role in human
disease and the way it is produced from phytol.
Received 4 October 2005; received after revision 24 February 2006; accepted 26 April 2006 相似文献
972.
McTaggart SJ 《Cellular and molecular life sciences : CMLS》2006,63(3):255-267
Isoprenoids are synthesized in all living organisms and are incorporated into diverse classes of end-products that participate
in a multitude of cellular processes relating to cell growth, differentiation, cytoskeletal function and vesicle trafficking.
In humans, the non-sterol isoprenoids, farnesyl pyrophosphate and geranylgeranyl-pyrophosphate, are synthesized via the mevalonate
pathway and are covalently added to members of the small G protein superfamily. Isoprenylated proteins have key roles in membrane
attachment and protein functionality, have been shown to have a central role in some cancers and are likely also to be involved
in the pathogenesis and progression of atherosclerosis and Alzheimer disease. This review details current knowledge on the
biosynthesis of isoprenoids, their incorporation into proteins by the process known as prenylation and the complex regulatory
network that controls these proteins. An improved understanding of these processe is likely to lead to the development of
novel therapies that will have important implications for human health and disease.
Received 5 July 2005; received after revision 17 October 2005; accepted 22 October 2005 相似文献
973.
Selenium is an essential trace element. In cattle, selenium deficiency causes dysfunction of various organs, including skeletal
and cardiac muscles. In humans as well, lack of selenium is associated with many disorders, but despite accumulation of clinical
reports, muscle diseases are not generally considered on the list. The goal of this review is to establish the connection
between clinical observations and the most recent advances obtained in selenium biology. Recent results about a possible role
of selenium-containing proteins in muscle formation and repair have been collected. Selenoprotein N is the first selenoprotein
linked to genetic disorders consisting of different forms of congenital muscular dystrophies. Understanding the muscle disorders
associated with selenium deficiency or selenoprotein N dysfunction is an essential step in defining the causes of the disease
and obtaining a better comprehension of the mechanisms involved in muscle formation and maintenance.
Received 13 July 2005; received after revision 9 September 2005; accepted 4 October 2005 相似文献
974.
Memories become stabilized through a time-dependent process that requires gene expression and is commonly known as consolidation. During this time, memories are labile and can be disrupted by a number of interfering events, including electroconvulsive shock, trauma and other learning or the transient effect of drugs such as protein synthesis inhibitors. Once consolidated, memories are insensitive to these disruptions. However, they can again become fragile if recalled or reactivated. Reactivation creates another time-dependent process, known as reconsolidation, during which the memory is restabilized. Here we discuss some of the questions currently debated in the field of memory consolidation and reconsolidation, the molecular and anatomical requirements for both processes and, finally, their functional relationship. 相似文献
975.
Galectin-7 总被引:4,自引:0,他引:4
Galectins are a family of animal lectins with an affinity for β-galactosides. They are differentially expressed by various
tissues and appear to be functionally multivalent, exerting a wide range of biological activities both during development
and in adult tissue. Galectin-7, a member of this family, contributes to different events associated with the differentiation
and development of pluristratified epithelia. It is also associated with epithelial cell migration, which plays a crucial
role in the re-epithelialization process of corneal or epidermal wounds. In addition, recent evidence indicates that galectin-7,
designated as the product of the p53-induced gene 1 (PIG1), is a regulator of apoptosis through JNK activation and mitochondrial
cytochrome c release. Defects in apoptosis constitute one of the major hallmarks of human cancers, and galectin-7 can act
as either a positive or a negative regulatory factor in tumour development, depending on the histological type of the tumour.
Received 30 October 2005; received after revision 15 November 2005; accepted 25 November 2005 相似文献
976.
Identification of rate-limiting steps or components of intracellular second messenger systems holds promise to effectively
interfere with these pathways under pathological conditions. The emerging literature on a recently identified family of signalling
regulator proteins, called tribbles gives interesting clues for how these proteins seem to link several ‘independent’ signal
processing systems together. Via their unique way of action, tribbles co-ordinate the activation and suppression of the various
interacting signalling pathways and therefore appear to be key in determining cell fate while responding to environmental
challenges. This review summarises our current understanding of tribbles function and also provides an evolutionary perspective
on the various tribbles genes.
Received 10 January 2006; received after revision 20 March 2006; accepted 5 April 2006 相似文献
977.
Amundadottir LT Sulem P Gudmundsson J Helgason A Baker A Agnarsson BA Sigurdsson A Benediktsdottir KR Cazier JB Sainz J Jakobsdottir M Kostic J Magnusdottir DN Ghosh S Agnarsson K Birgisdottir B Le Roux L Olafsdottir A Blondal T Andresdottir M Gretarsdottir OS Bergthorsson JT Gudbjartsson D Gylfason A Thorleifsson G Manolescu A Kristjansson K Geirsson G Isaksson H Douglas J Johansson JE Bälter K Wiklund F Montie JE Yu X Suarez BK Ober C Cooney KA Gronberg H Catalona WJ Einarsson GV 《Nature genetics》2006,38(6):652-658
With the increasing incidence of prostate cancer, identifying common genetic variants that confer risk of the disease is important. Here we report such a variant on chromosome 8q24, a region initially identified through a study of Icelandic families. Allele -8 of the microsatellite DG8S737 was associated with prostate cancer in three case-control series of European ancestry from Iceland, Sweden and the US. The estimated odds ratio (OR) of the allele is 1.62 (P = 2.7 x 10(-11)). About 19% of affected men and 13% of the general population carry at least one copy, yielding a population attributable risk (PAR) of approximately 8%. The association was also replicated in an African American case-control group with a similar OR, in which 41% of affected individuals and 30% of the population are carriers. This leads to a greater estimated PAR (16%) that may contribute to higher incidence of prostate cancer in African American men than in men of European ancestry. 相似文献
978.
Sayer JA Otto EA O'Toole JF Nurnberg G Kennedy MA Becker C Hennies HC Helou J Attanasio M Fausett BV Utsch B Khanna H Liu Y Drummond I Kawakami I Kusakabe T Tsuda M Ma L Lee H Larson RG Allen SJ Wilkinson CJ Nigg EA Shou C Lillo C Williams DS Hoppe B Kemper MJ Neuhaus T Parisi MA Glass IA Petry M Kispert A Gloy J Ganner A Walz G Zhu X Goldman D Nurnberg P Swaroop A Leroux MR Hildebrandt F 《Nature genetics》2006,38(6):674-681
979.
980.